This document is a publication of a United States Patent and Trademark Office (USPTO) patent application, specifically application number US20260083941A1, filed on November 24, 2025. The application describes a novel method for treating urinary catheters by using a nitric oxide generating solution. This solution is created by mixing a liquid carrier with a powder formulation containing an S-nitrosothiol (RSNO). The generated solution is then introduced into the inflatable and nitric oxide permeable balloon of a urinary catheter inserted into a patient within a specified timeframe after mixing.

As this is a patent application, it does not impose immediate regulatory requirements or compliance deadlines on regulated entities. However, it signals potential future developments in medical device technology, specifically for urinary catheters. Companies involved in the manufacturing or development of such devices, particularly those focusing on antimicrobial properties or advanced catheter designs, should be aware of this filing. The patent application is published for public record and does not require any action from compliance officers at this stage, but it may inform future R&D and intellectual property strategies.